Other languages OmniAb, Inc.

Equities

OABI

US68218J1034

Real-time Estimate Cboe BZX Other stock markets 03:53:04 2024-04-29 pm EDT			5-day change	1st Jan Change
4.555 ^USD	+1.67%		-3.10%	-26.50%

Mar. 25	OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing	MT
Mar. 21	Sector Update: Health Care Stocks Gain Pre-Bell Thursday	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing	Mar. 25
Sector Update: Health Care Stocks Gain Pre-Bell Thursday	Mar. 21
OmniAb Swings to Q4 Loss, Revenue Declines	Mar. 20
OmniAb, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 20
OmniAb, Inc. Presents New Scientific Data on its OmnidAb Platform at the 2023 Antibody Engineering & Therapeutics Conference	Dec. 14
Omniab Insider Bought Shares Worth $1,010,000, According to a Recent SEC Filing	Dec. 13
Omniab Insider Bought Shares Worth $405,517, According to a Recent SEC Filing	Nov. 13
OmniAb, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Omniab, Inc. Appoints Steve Love to Its Board of Directors and as Audit Committee Chair, Member of the Human Capital Management and Compensation Committee	Nov. 01
A Collaborative Scientific Team Led by Researchers At the Applied Biomedical Science Institute, Scripps Research, Kansas State University, University of Louisville, Omniab, Inc., and Ligand Pharmaceuticals Discovers and Validates Potential New Class of Therapeutic Agent Based on the Unique Antigen Binding Regions of Cow Antibodies	23-09-20
Insider Buy: Omniab	23-08-15
OmniAb, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Omniab Announces the Passing of Director Sunil Patel	23-08-07
Hillstream Expands Collaboration With Minotaur, License Deal With OmniAb to Develop Cancer Treatments; Shares Rise	23-07-20
Insider Buy: Omniab	23-06-12
Insider Sell: Omniab	23-05-19
Insider Buy: Omniab	23-05-15
OmniAb, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Sector Update: Health Care Stocks Mixed Premarket Friday	23-03-31
OmniAb Swings to Q4 Earnings as Revenue More Than Doubles	23-03-31

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages OmniAb, Inc.

Equities

OABI

US68218J1034

Other languages

Filters